Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...

Scientists have developed a blood test that can help predict which breast cancer treatment will work best. The team at the ...

A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs that are initially effective lose their potency over time, as malignant ...

More than 70% of people diagnosed with cancer in the United States now survive for five years or more, a milestone experts ...

The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.

Tumours often feature high chromosomal instability. “And chromosomal instability leads to further chromosomal instability,” says Peter Van Loo of The University of Texas MD Anderson Cancer Center's ...

Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments and diagnostics easier and quicker, new research has found. Working with ...

Hereditary breast cancer results from inherited mutations, primarily in BRCA1 and BRCA2, increasing lifetime cancer risk. Additional genes like TP53, PTEN, PALB2, CHEK2, and ATM also contribute to ...

About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...